January 17, 2022, 17:18

    Thyssenkrupp hydrogen business eyes up to $687 mln in IPO proceeds

    Thyssenkrupp hydrogen business eyes up to $687 mln in IPO proceeds

    • Hydrogen business rebranded Nucera
    • Nucera could be floated in IPO in spring
    • Nucera had sales of 319 mln euros, EBIT of 27 mln in 2020/21

    FRANKFURT/DUESSELDORF, Jan 13 (Reuters) – Thyssenkrupp's(TKAG.DE)electrolysis business is aiming for proceeds of up to 600 million euros ($687 million) by selling new shares in a possible initial public offering this year, betting on the booming hydrogen sector it supplies with equipment.

    Thyssenkrupp plans to keep a majority in the business – which is being rebranded as Thyssenkrupp Nucera – following any IPO and aims to maintain the current shareholding ratio with its Italian co-owner De Nora (IPO-DENR.MI), said Volkmar Dinstuhl, who leads the conglomerate's Multi Tracks division.

    This implies a free-float of up to 25%.

    Register now for FREE unlimited access to Reuters.comRegister

    The 500 million-600 million in potential proceeds would correspond to a stake sale of roughly 10-20% based on a valuation range of 3 billion to 6 billion euros that analysts have put on the division, which could be listed in the spring.

    Thyssenkrupp Nucera is the world's top supplier of chlor-alkali membrane technologies needed to produce hydrogen, competing with Japan's Asahi Kasei (3407.T), China's Bluestar Beijing Chemical Machinery and Britain's chemicals group Ineos (INEOSE.UL).

    It is also active in alkaline water electrolysis, a key requirement for the generation of hydrogen produced via renewable energy, pitting it against Norway's Nel ASA (NEL.OL), UK's ITM Power (ITM.L) and France's McPhy Energy SAS (MCPHY.PA).

    "Demand is huge. We want to use that opportunity," Denis Krude, CEO of Thyssenkrupp Nucera, told Reuters ahead of a capital markets on Thursday where investors are getting more detail on the business for the first time.

    "We are a technology leader for electrolysis and have been in the business for decades," Krude, who has led the division since October 2016, said.

    In the fiscal year that ended in September, Thyssenkrupp Nucera posted earnings before interest and tax of 27 million euros while sales came in at 319 million euros, a level expected to triple to 900 million to 1 billion euros by 2025/26.

    The potential proceeds from selling new shares do not factor in the sale of existing stakes by current owners Thyssenkrupp and De Nora, which own Thyssenkrupp Nucera in a 66/34 split.

    Thyssenkrupp, which first floated the idea of an IPO of its hydrogen business in May last year, declined to say how much it would sell as part of a secondary offering in case of an IPO. read more

    "The market has enormous potential," Krude said, adding Nucera would invest 200 million to 300 million by 2024/25, of which 150 million-200 million will be spent on strategic moves including partnerships, production and smaller deals.

    Europe, most notably Germany, wants to be a world leader in green hydrogen, which is generated via renewable sources and is carbon-neutral, to cut emissions and decarbonise its economy.

    Thyssenkrupp, which makes everything from steel and submarines to car parts and fertiliser plants, sees an IPO as the preferred option for Nucera but has not made a final decision.

    "For the Thyssenkrupp group the most important thing in a possible IPO is the so-called value crystallisation," said Dinstuhl.

    ($1 = 0.8738 euro)

    Register now for FREE unlimited access to Reuters.comRegisterReporting by Christoph Steitz in Frankfurt and Tom Kaeckenhoff in Duesseldorf
    Editing by Matthew Lewis and Jane Merriman

    Sourse: reuters.com

    Related posts

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies. You can find a detailed description in our Privacy Policy.
    Accept
    Reject
    Privacy Policy